| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/04/1996 | CA2192711A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 01/03/1996 | EP0690129A1 Novel entities for cancer therapy |
| 01/03/1996 | EP0690125A2 Process for induction culture of cytotoxict lymphocytes having killing activity against tumor cells |
| 01/03/1996 | EP0690048A1 Ortho-amino substituted benzoylguanidines, process for their preparation, their use as medicine or diagnostic and medicines containing them |
| 01/03/1996 | EP0689845A2 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
| 01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
| 01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0689549A1 New urea derivates, their preparation and their use |
| 01/03/1996 | EP0689537A1 Method and apparatus for extracting taxol from source materials |
| 01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 01/03/1996 | EP0689447A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 01/03/1996 | EP0689436A1 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0689427A1 Water dispersible therapeutic compounds |
| 01/03/1996 | EP0689426A1 Therapeutic agent for the treatment of melanomas |
| 01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 01/03/1996 | CN1114506A Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 01/03/1996 | CN1030610C Crystalline etoposide 4'-phosphate diethanolate |
| 01/03/1996 | CN1030608C Method of preparation for N-(pyrroloÛ2,3-dÙ pyrimidin-3-ylacyl)-glutamic acid derivatives |
| 01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
| 01/02/1996 | US5480906 Antitumor agents |
| 01/02/1996 | US5480893 Antitumor |
| 01/02/1996 | US5480878 Method for treating prostatic hypertrophy with estradiol derivatives |
| 01/02/1996 | US5480873 Arthritis |
| 01/02/1996 | US5480870 Heptapeptide and octapeptide amide derivatives; treatment of excessive secretion of insulin, glucagon or growth hormone |
| 01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
| 12/30/1995 | CA2152878A1 Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 12/30/1995 | CA2152233A1 Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
| 12/28/1995 | WO1995035321A1 Antibodies against t-cells as therapeutics |
| 12/28/1995 | WO1995035314A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 12/28/1995 | WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 12/28/1995 | WO1995035297A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 12/28/1995 | WO1995035276A1 Metalloproteinase inhibitors |
| 12/28/1995 | WO1995035275A1 Metalloproteinase inhibitors |
| 12/28/1995 | WO1995035102A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 12/28/1995 | WO1995029917A3 Intermediates in pharmaceutical camptothecin preparation |
| 12/28/1995 | WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation |
| 12/28/1995 | CA2193692A1 Metalloproteinase inhibitors |
| 12/28/1995 | CA2193691A1 Metalloproteinase inhibitors |
| 12/28/1995 | CA2193092A1 Antibodies against t cells as therapeutics |
| 12/28/1995 | CA2192950A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 12/27/1995 | EP0688784A2 3'-Modified oligonucleotide derivatives |
| 12/27/1995 | EP0688783A1 Method for preparing 2',deoxy-2',2'-difluornucleosides |
| 12/27/1995 | EP0688782A1 Stereoselective process for preparing protected 2',2'-difluorolactonen |
| 12/27/1995 | EP0688766A1 Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 12/27/1995 | EP0688432A1 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor |
| 12/27/1995 | EP0688324A1 Novel 3-(substituted methyl)-4-oxa-1-azabicyclo 3.2.0]heptan-7-one derivatives useful as antitumor agents |
| 12/27/1995 | EP0688315A1 New heterocyclic compounds, their preparation and their use |
| 12/27/1995 | EP0688228A1 COMPOSITONS COMPRISING IgG 3? ANTIBODIES |
| 12/27/1995 | EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles |
| 12/27/1995 | EP0688224A1 A mutant protein and methods and materials for making and using it |
| 12/27/1995 | EP0688213A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 12/27/1995 | EP0688212A1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
| 12/27/1995 | EP0579646B1 Anti-cancer antracene derivatives |
| 12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
| 12/27/1995 | CN1113790A Anti-cancer Chinese drug-Xiaoliujing capsule |
| 12/27/1995 | CN1113789A Anti-cancer compound preparation |
| 12/26/1995 | US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them |
| 12/26/1995 | US5478942 Cyclic urea derivatives and pharmaceutical compositions containing these compounds |
| 12/26/1995 | US5478861 Cytotoxic macrolides and methods of use |
| 12/26/1995 | US5478818 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative |
| 12/26/1995 | US5478806 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 12/26/1995 | CA2004534C Metallo-organic compounds and uses thereof |
| 12/26/1995 | CA1337802C Antibiotics tan-1057 |
| 12/26/1995 | CA1337800C Monoclonal antibody recognizing alpha 2 --> 3 bonds |
| 12/21/1995 | WO1995034652A1 Calcium binding recombinant antibody against protein c |
| 12/21/1995 | WO1995034638A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 12/21/1995 | WO1995034565A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 12/21/1995 | WO1995034563A1 Pyrazolo and pyrrolopyridines |
| 12/21/1995 | WO1995034559A1 Novel compound, process for producing the same, and antitumor agent |
| 12/21/1995 | WO1995034557A1 2-AMINO-3-AROYL-BENZO[β]THIOPHENES AND METHOD OF MAKING THE SAME |
| 12/21/1995 | WO1995034544A1 Bioactive acetogenins and derivatives |
| 12/21/1995 | WO1995034535A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 12/21/1995 | WO1995034319A1 Compositions and methods for the treatment of tumors |
| 12/21/1995 | WO1995034316A1 Suppression of tumor cell growth by syndecan-1 ectodomain |
| 12/21/1995 | WO1995034201A1 pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 12/21/1995 | WO1995032731A3 Immunogenic pharmaceuticals |
| 12/21/1995 | WO1995030761A3 Methods of in vivo gene delivery |
| 12/21/1995 | WO1995027066A3 Dna encoding ubiquitin conjugating enzymes |
| 12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
| 12/21/1995 | CA2192977A1 Bioactive acetogenins and derivatives |
| 12/21/1995 | CA2192972A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 12/21/1995 | CA2192655A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 12/21/1995 | CA2192593A1 Suppression of tumor cell growth by syndecan-1 ectodomain |
| 12/21/1995 | CA2192486A1 Pp60pik: a downstream element in insulin signaling |
| 12/21/1995 | CA2192389A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 12/21/1995 | CA2192097A1 2-amino-3-aroyl-benzo¬.beta.|thiophenes and method of making the same |
| 12/21/1995 | CA2191065A1 Compositions and methods for the treatment of tumors |
| 12/20/1995 | EP0687673A1 Oxazole derivatives as antitumoral agents |
| 12/20/1995 | EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 12/20/1995 | EP0687260A1 Process for the preparation of 9-desoxotaxanes |
| 12/20/1995 | EP0687259A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 12/20/1995 | EP0687253A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 12/20/1995 | EP0687249A1 Balanoids |
| 12/20/1995 | EP0679082A4 C10 taxane derivatives and pharmaceutical compositions. |
| 12/20/1995 | EP0668762A4 Butenyl-substituted taxanes and composition. |